Ces radiol. 2025, 79(1):45-51 | DOI: 10.55095/CesRadiol2025/006
Radiologically isolated syndrome (new criteria) - shifting MS diagnosis to preclinical stageReview article
- 1 Oddělení MR, Radiodiagnostická klinika 1. LF UK a VFN, Praha
- 2 Radiologická klinika LF UK a FN, Hradec Králové
- 3 Neurologická klinika a Centrum klinických neurověd 1. LF UK a VFN, Praha
Radiologically isolated syndrome (RIS) is defined as an incidental finding on magnetic resonance imaging (MRI) that is typical of multiple sclerosis (MS) in a patient without clinical symptoms of the disease. This term, along with its definition criteria, was first introduced in 2009. The newly revised 2023 RIS criteria aim to provide a more accurate and faster diagnosis compared to the original 2009 criteria. These criteria require at least one T2-hyperintense lesion in one of the four typical locations for MS, along with two of the following three features: spinal cord lesions, oligoclonal bands confined to the cerebrospinal fluid (but absent in the serum), or a new T2-hyperintense lesion (or, after contrast administration, a prominent lesion visible on follow-up MRI scans). An MRI diagnosis of RIS establishes a risk factor for conversion to clinically definite MS and a more severe disease course. These risk factors include the patient's age, the location of the lesions (infratentorial and intramedullary), and the presence of oligoclonal bands in the cerebrospinal fluid. These factors are critical when considering therapeutic interventions. Recent clinical trials have demonstrated that oral disease-modifying therapies can delay or prevent the first clinical event in patients with RIS. This shift in diagnosis and treatment considerations to preclinical stages places enormous pressure on ensuring precise diagnosis and management. It is essential that such patients are referred to MS centers for further specialized investigations. The forthcoming Revised McDonald Criteria of 2024 will classify individuals with additional cerebrospinal fluid markers and advanced MRI biomarkers as having preclinical MS. This highlights the importance of precise diagnosis and the need for radiologists and neurologists to familiarize themselves with the appropriate steps to ensure patients are monitored at highly specialized MS care centers.
Keywords: radiology isolated syndrome, multiple sclerosis, magnetic resonance imaging, subclinical, prodromal, diagnostic protocol.
Accepted: January 31, 2025; Published: April 22, 2025 Show citation
References
- . Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 2009; 72(9): 800-805.
Go to original source...
Go to PubMed...
- . Lebrun C. The radiologically isolated syndrome. Rev Neurol. (Paris) 2015; 171(10): 698-706.
Go to original source...
Go to PubMed...
- . Okuda DT, Siva A, Kantarci O, et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS ONE 2014; 9(3): e90509.
Go to original source...
Go to PubMed...
- . Lebrun-Frenay C, Kantarci O, Siva A, et al. 10-year RISC study group on behalf of SFSEP, OFSEP. Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event. Ann Neurol. 2020; 88(2): 407-417. doi:10.1002/ana.25799 [Epub 2020 Jun 29]. PMID: 32500558.
Go to original source...
Go to PubMed...
- . Lebrun-Frenay C. The confavreux lecture: The radiologically isolated syndrome diagnosis, prognosis and perspectives. Mult Scler. 2025; 13524585241311217.
Go to original source...
Go to PubMed...
- . Hosseiny M, Newsome SD, Yousem DM. Radiologically Isolated Syndrome: A Review for Neuroradiologists. AJNR Am J Neuroradiol. 2020; 41(9): 1542-1549.
Go to original source...
Go to PubMed...
- . Lebrun-Frénay C, Okuda DT, Siva A, et al. The radiologically isolated syndrome: revised diagnostic criteria. Brain 2023; 146(8): 3431-3443.
Go to original source...
Go to PubMed...
- . Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018; 17(2): 162-173.
Go to original source...
Go to PubMed...
- . Wattjes MP, Ciccarelli O, Reich DS, et al. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. The Lancet Neurology 2021; 20(8): 653-670.
Go to original source...
Go to PubMed...
- . Vaněčková M, Horáková D, Šťastná D, et al. Standardizace využití MR v managementu roztroušené sklerózy: Konsenzus českého expertního radiologicko-neurologického panelu. Cesk Slov Neurol N. 2024; 87/120(1): 69-77.
- . Vaněčková M, Šťastná D, Ryška P, et al. Standardizace využití MR v diagnostice a monitoraci roztroušené sklerózy v České republice. Ces Radiol. 2024; 78(2): 101-114.
Go to original source...
- . Meaton I, Altokhis A, Allen CM, et al. Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis. Mult Scler. 2022; 28(14): 2212-2220.
Go to original source...
Go to PubMed...
- . Suthiphosuwan S, Sati P, Guenette M, et al. The Central Vein Sign in Radiologically Isolated Syndrome. AJNR Am J Neuroradiol. 2019; 40(5): 776-783.
Go to original source...
Go to PubMed...
- . Cagol A, Cortese R, Barakovic M, et al. Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis. JAMA Neurol. 2024; 81(2): 143-153.
Go to original source...
Go to PubMed...
- . Brownlee WJ, Vidal-Jordana A, Shatila M, et al. MAGNIMS Study Group. Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis. Ann Neurol. 2024 Nov 28. doi:10.1002/ana.27145
Go to original source...
Go to PubMed...
- . Vidal-Jordana A, Rovira A, Calderon W, et al. Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study. Neurology 2024; 102(1): e200805.
Go to original source...
Go to PubMed...
- . Rojas JI, Patrucco L, Míguez J, et al. Brain atrophy in radiologically isolated syndromes. J Neuroimaging 2015; 25(1): 68-71.
Go to original source...
Go to PubMed...
- . Labiano-Fontcuberta A, Mato-Abad V, Álvarez-Linera J, et al. Normal-appearing brain tissue analysis in radiologically isolated syndrome using 3 T MRI. Medicine (Baltimore) 2016; 95(27): e4101.
Go to original source...
Go to PubMed...
- . Labiano-Fontcuberta A, Mato-Abad V, Álvarez-Linera J, et al. Gray Matter Involvement in Radiologically Isolated Syndrome. Medicine (Baltimore) 2016; 95(13): e3208.
Go to original source...
Go to PubMed...
- . Okuda DT, Kantarci O, Lebrun-Frénay C, et al. Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome. Ann Neurol. 2023; 93(3): 604-614.
Go to original source...
Go to PubMed...
- . Lebrun-Frénay C, Siva A, Sormani MP, et al. Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial. JAMA Neurol. 2023; 80(10): 1080-1088.
Go to original source...
Go to PubMed...
- . Lebrun-Frenay C, Kerbrat S, Okuda DT, et al. Analysis of healthcare utilization before the diagnosis of radiologically isolated syndrome. Mult Scler. 2025; 13524585241291471.
Go to original source...
Go to PubMed...
- . Tremlett H, Marrie RA. The multiple sclerosis prodrome: Emerging evidence, challenges, and opportunities. Mult Scler. 2021; 27(1): 6-12. doi:10.1177/1352458520914844 [Epub 2020 Mar 31]. PMID: 32228281.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.